Table 4.
Gender | Variable | β coefficient | Std. error | Significance |
---|---|---|---|---|
Female | Intercept | −19.934 | 11.910 | 0.094 |
Disease duration | 0.103 | 0.292 | 0.724 | |
Age at assessment | 0.432 | 0.196 | 0.027 | |
Total levodopa equivalent | 0.005 | 0.003 | 0.081 | |
Hcy | 0.375 | 0.274 | 0.170 | |
| ||||
Male | Intercept | −15.341 | 7.106 | 0.031 |
Disease duration | 0.719 | 0.186 | <0.001 | |
Age at assessment | 0.354 | 0.105 | 0.001 | |
Total levodopa equivalent | −0.002 | 0.002 | 0.370 | |
Hcy | 0.766 | 0.264 | 0.004 |